Mr. Spaight has served as an Operating Partner in the Healthcare Group at Arsenal Capital Partners, a New York City-based private equity firm. Previously, Mr. Spaight served as Chairman and CEO of WIL Research, President of MDS Pharma Services, Senior Vice-President of Fisher Scientific Products and Vice-President at PerkinElmer. Mr. Spaight currently serves on the board of directors of , CellCarta, a provider of specialized research services in the development of immunology and oncology focused drugs. Mr. Spaight also served as Executive Chairman of the board of directors of BioIVT, LLP, a provider of biospecimens for drug discovery; Executive Chairman of OncoHealth, Inc., a provider of oncology utilization management and cancer care support services; and Executive Chairman of Accumen, a provider of 3D medical image post-processing and technology enabled solutions to optimize clinical laboratories and imaging departments. He also served as Chairman of the Association of Clinical Research Organizations (ACRO) and was member of the ACRO board of directors for four years.

Spaight holds a BS in Chemistry and an MBA, both earned from the University of Michigan.